PA-25-174-Full-Announcement.html

This document is a Notice of Funding Opportunity (NOFO) for the Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed) grant opportunity. The National Cancer Institute (NCI) is soliciting R01 research projects to study the effects of different types of radiation used in radionuclide-based cancer therapeutics on normal tissue, tumor cells, and the tumor microenvironment. Eligible applicant types include special district governments, nonprofits, for-profit organizations, and higher education institutions, among others. The funding activity categories are education and health. This grant opportunity is assigned to the Cancer Detection and Diagnosis Research (93.394) and Cancer Treatment Research (93.395) federal grant programs under the Department of Health and Human Services National Institutes of Health.